DB00689ApprovedSmall molecule
A cephalorsporin antibiotic that is no longer commonly used.
- Mechanism
- Curator reviewed
The bactericidal activity of cephaloglycin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
- Primary indication
- For treatment of severe infections caused by susceptible bacteria.Curator reviewed
- Formula / weight
- C18H19N3O6S · 405.425 g/mol (avg)
- Also known as
- Cefaloglycin · Cephaloglycine · Cephaoglycin acid · D-Cephaloglycine
Resolves to
Clinical / RWD
Structure
InChIKey
FUBBGQLTSCSAON-PBFPGSCMSA-NSMILES[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=OTargets
Transporters
What you can answer from here — as of October 01, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
1TransporterSubstrate / inhibitor direction, not just membershipListed above
Which drugs share a target with Cephaloglycin, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account